Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
-
02/01/2018
-
Neurology
The objective of the study was to investigate the kinetics and metabolism of caffeine in serum from patients with Parkinson disease (PD) and controls using liquid chromatography–mass spectrometry.